NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N HSQC | 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor | 90% H2O/10% D2O | 0 M | 6.5 | 1 atm | 303.15 | Varian INOVA 600 |
2 | 3D HNCACB | 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor | 90% H2O/10% D2O | 0 M | 6.5 | 1 atm | 303.15 | Varian INOVA 600 |
3 | 3D HNCO | 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor | 90% H2O/10% D2O | 0 M | 6.5 | 1 atm | 303.15 | Varian INOVA 600 |
4 | 3D 1H-15N NOESY | 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor | 90% H2O/10% D2O | 0 M | 6.5 | 1 atm | 303.15 | Varian INOVA 600 |
5 | 3D 1H-15N TOCSY | 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor | 90% H2O/10% D2O | 0 M | 6.5 | 1 atm | 303.15 | Varian INOVA 600 |
6 | 3D 1H-13C NOESY (edited) | 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor | 90% H2O/10% D2O | 0 M | 6.5 | 1 atm | 303.15 | Varian INOVA 600 |
7 | 3D 1H-13C NOESY (filtered) | 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor | 90% H2O/10% D2O | 0 M | 6.5 | 1 atm | 303.15 | Varian INOVA 600 |